Physician profile
Amardeep Singh
NPI 1871120915
$901.11
in general payments reported to CMS, 2019-2025
14 companies · $633 in 2025
The $633 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $24.58 · 2024: $244 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $178.75 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $146.73 | 2024-2025 | |
| Amgen INC. | $92.19 | 2025 | Krystexxa, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $90.45 | 2024-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $89.56 | 2025 | Zepbound, Mounjaro |
| Abbvie INC. | $86.24 | 2025 | |
| Exact Sciences Corporation | $70.15 | 2024-2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $25.82 | 2025 | General - Therapies |
| Dexcom, INC. | $24.58 | 2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $23.66 | 2025 | Freestyle Libre |
| Hologic Sales and Service, LLC | $21.43 | 2025 | Aptima |
| Inspire Medical Systems, INC. | $21.38 | 2024 | Inspire |
| Becton, Dickinson and Company | $16.75 | 2024 | Bd Max System, Bd Max Instrument |
| Agios Pharmaceuticals, INC. | $13.42 | 2024 | Pyrukynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amardeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.